Spruce Biosciences Stock Probability of Future Stock Price Finishing Over 0.48
| SPRB Stock | USD 0.48 0.01 2.04% |
Spruce |
Spruce Biosciences Target Price Odds to finish over 0.48
The tendency of Spruce Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.48 | 90 days | 0.48 | about 58.74 |
Based on a normal probability distribution, the odds of Spruce Biosciences to move above the current price in 90 days from now is about 58.74 (This Spruce Biosciences probability density function shows the probability of Spruce Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Spruce Biosciences has a beta of 0.85. This usually implies Spruce Biosciences market returns are sensitive to returns on the market. As the market goes up or down, Spruce Biosciences is expected to follow. Additionally Spruce Biosciences has an alpha of 4.0E-4, implying that it can generate a 4.39E-4 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Spruce Biosciences Price Density |
| Price |
Predictive Modules for Spruce Biosciences
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Spruce Biosciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Spruce Biosciences Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Spruce Biosciences is not an exception. The market had few large corrections towards the Spruce Biosciences' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Spruce Biosciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Spruce Biosciences within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.0004 | |
β | Beta against Dow Jones | 0.85 | |
σ | Overall volatility | 0.05 | |
Ir | Information ratio | -0.0056 |
Spruce Biosciences Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Spruce Biosciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Spruce Biosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Spruce Biosciences has some characteristics of a very speculative penny stock | |
| Spruce Biosciences had very high historical volatility over the last 90 days | |
| Spruce Biosciences has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 10.09 M. Net Loss for the year was (47.92 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Spruce Biosciences currently holds about 93.3 M in cash with (33.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.96, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Spruce Biosciences has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Spruce Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com |
Spruce Biosciences Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Spruce Stock often depends not only on the future outlook of the current and potential Spruce Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Spruce Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 38.5 M | |
| Cash And Short Term Investments | 96.3 M |
Spruce Biosciences Technical Analysis
Spruce Biosciences' future price can be derived by breaking down and analyzing its technical indicators over time. Spruce Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Spruce Biosciences. In general, you should focus on analyzing Spruce Stock price patterns and their correlations with different microeconomic environments and drivers.
Spruce Biosciences Predictive Forecast Models
Spruce Biosciences' time-series forecasting models is one of many Spruce Biosciences' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Spruce Biosciences' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Spruce Biosciences
Checking the ongoing alerts about Spruce Biosciences for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Spruce Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Spruce Biosciences has some characteristics of a very speculative penny stock | |
| Spruce Biosciences had very high historical volatility over the last 90 days | |
| Spruce Biosciences has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 10.09 M. Net Loss for the year was (47.92 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Spruce Biosciences currently holds about 93.3 M in cash with (33.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.96, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Spruce Biosciences has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Spruce Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com |
Check out Spruce Biosciences Backtesting, Spruce Biosciences Valuation, Spruce Biosciences Correlation, Spruce Biosciences Hype Analysis, Spruce Biosciences Volatility, Spruce Biosciences History as well as Spruce Biosciences Performance. For information on how to trade Spruce Stock refer to our How to Trade Spruce Stock guide.You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Spruce Biosciences. If investors know Spruce will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Spruce Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.95) | Revenue Per Share 0.173 | Quarterly Revenue Growth (0.80) | Return On Assets (0.30) | Return On Equity (0.58) |
The market value of Spruce Biosciences is measured differently than its book value, which is the value of Spruce that is recorded on the company's balance sheet. Investors also form their own opinion of Spruce Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Spruce Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Spruce Biosciences' market value can be influenced by many factors that don't directly affect Spruce Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Spruce Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Spruce Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Spruce Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.